3Ta Wynn. Cellular and molecular mechanisms of fibrosis. J pathol,2008 January,214(2) :199 - 120.
4Friedman SL. Hepatic fibrosis--overiew. Toxicology,2008,254 : 120 - 129.
5Boderfeld M,Rath T,Veswindkel R,et al. Bone marrow transplantation dens- onstrates medullar origin of CD34 4- fdvrocytes and ameliorates hepatic fibrmis in Ahcb4 - / - mice. Hepatology ,9.010,51 ( 1 ) :9.67 -76.
6Ehihara Y,Masuya M,Lame AC. Henatopoletic origins of fibmblnsts: II In vitro studies of fthrohlasts, CFU- F,and fibrocytes. Exp Hematol,2006,34 (2) :219 -229.
7Russo FP, MR Alison, BW Bigger. The bone marrow functionally oontributes to liver fibrosis. Gastroenterology,2006,130 : 1807 - 1821.
8Kalmori A, Potter J, Kaimori JY, et al. Transforming growth factor - betal induces an epithelial - to - mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem,2007,282:22089 - 22101. PMID:IT513865.
9Diaz R, Kim JW, Hui JJ, et al. Evidence for the epithelial to mesenchymal transition in hiliary atresia fibrosis. Hum Pathol,2008,39:102 - 115. PMID: 17900655.
10Meneghin MD, Hogaboam C. Infectious disease, the innate immune response, and fibrosis. J Clin invest,2007,117 (3) :530 - 538.
7Friedman SL.Seminars in medicine of the Beth Israel Hospital,Boston.The cellular basis of hepatic fibrosis.Mechanisms and treatment strategies.N Engl J Med,1993,328:1828-1835.
8Gressner AM.Mediators of hepatic fibrogenesis.Hepatogastroenterology,1996,43:92-103.
9Pinzani M,Marra F,Carloni V.Signal transduction in hepatic stellate cells.Liver,1998,18:2-13.
10Xu L,Hui AY,Albanis E,et al.Human hepatic stellate cell lines,LX-1 and LX-2:new tools for analysis of hepatic fibrosis.Gut,2005,54:142-151.
1Ismail MH, Pinzani M. Reversal of liver fibrosis[J]. Saudi J Gastroenterol, 2009,15:72-79.
2Thabut D, Shah V. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?[J]. J Hepatol,2010,53:976-980.
3Lin J, Tang Y, Kang Q, et al. Curcumin eliminates theinhibitory effect of advanced glycation end-products (AGEs) on gene expression of AGE receptor- 1 in hepatic stellate cells in vitro[J]. March,2012,92:827- 841.
4Llorente-Cortes V, Barbarigo V, Badimon L. Low density lipoprotein receptor-related protein 1 modulates the proliferation and migration of human hepatic stellate cells[J]. J Cell Physiol,2012,227:3528-3533.
5Kuo J J, Wang CY, Lee TF, et al. Paeoniae radix reduces PDGF- stimulated hepatic stellate cell migration[J]. Planta Med,2012,78:341- 348.
6Murphy FR, Issa R, Zhou X, et al. Inhibition of apoptosis activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis[J]. J Biol Chem,2012,277: 11069-11076.
7Sferra R, Vetuschi A, Catitti V, et al. Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-betal downregulation[J]. Eur Rev Med Pharmacol Sci,2012, 16:1484-1498.
8Liu L, Li X, Chen L, et al. The effect of gypenosides on TGF-β1/Smad pathway in liver fibrosis induced by carbon tetrachloridein rats[J]. Int J Integr Med,2013,1:1-6.
